Joint Venture Ineos and Sinopec Break Ground on the Largest Phenol Acetone Plant in China

Editor: Tobias Hüser

Ineos Phenol and Sinopec Yangzi Petrochemical Company have broken ground on the largest Phenol and Acetone plant to ever built in China. The ground-breaking ceremony for the 1,2 million tonne development was held in Nanjing Chemical Industry Park (NCIP). Ineos largest investment in China will be complete at the end of 2016, officials say.

Related Companies

The National Development and Reform Commission (NRDC) has given it´s approval for the 650,000 t phenol/acetone and 550,000 t cumene facility to be built in Nanjing/China.
The National Development and Reform Commission (NRDC) has given it´s approval for the 650,000 t phenol/acetone and 550,000 t cumene facility to be built in Nanjing/China.
(Picture: Process)

Nanjing/China – Ineos and Sinopec YPC have established a 50 % / 50 % joint venture company with a total investment of approximately $ 0.5 billion which will generate annual sales revenue of around $ 0.8 billion. It is expected that the new plant will be completed and operational by the end of 2016.

The project achieved regulatory approval by National Development Reform Commission (NDRC) on the 27th August. In addition the Jiangsu Province and Nanjing Municipal Government gave the green light to progress the project and start building the plant.

The new Joint Venture partnership will benefit from Sinopec's local feedstock advantages and cumene technology alongside Ineos proprietary phenol technology. The annual capacity of the new facility will be at least 400,000 t of phenol and 250,000 t of acetone. It will also include 550,000 t/a of cumene capacity. Together, with associated infrastructure, the Joint Venture will be the largest capital investment ever undertaken by Ineos in China.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:42328263)